Mobile Site ›
Print Friendly View

Test ID: MAPTM    
MAPT Gene, Sequence Analysis, 7 Exon Screening Panel

Secondary ID A test code used for billing and in test definitions created prior to November 2011

87924

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Aiding in the diagnosis of frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, and dementia with epilepsy

 

Distinguishing the diagnosis of frontotemporal dementia from other dementias, including Alzheimer dementia

 

Identifying individuals who are at risk of frontotemporal dementia

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR)/DNA Sequencing Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

MAPT Screening Sequence Analysis

Aliases Lists additional common names for a test, as an aid in searching

Frontotemporal dementia
Microtubule-associated protein tau
Pick's disease
Tau
Tauopathy